Dimension Capital Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-16,661
Closed -$14.6K 115
2022
Q4
$14.6K Hold
16,661
﹤0.01% 108
2022
Q3
$11K Buy
+16,661
New +$36.3K ﹤0.01% 102

Other funds holding RNLX

Dimension Capital Management's RNLX Position: Q1 2023 in Review

Dimension Capital Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2023, closing a stake of 16,661 shares — an estimated $14.6K sold.

Dimension Capital Management first reported a position in RNLX in Q3 2022 and held it in 2 quarters. The position peaked at $14.6K in Q4 2022. 18 funds tracked by Wall St. Rank hold RNLX as of Q1 2023.

  • Dimension Capital Management reported no remaining Renalytix plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Dimension Capital Management sold 16,661 Renalytix plc American Depositary Shares shares in Q1 2023, an estimated $14.6K.
  • Dimension Capital Management first reported a position in Renalytix plc American Depositary Shares in Q3 2022 and held it in 2 quarters.
  • Dimension Capital Management's Renalytix plc American Depositary Shares position peaked at $14.6K in Q4 2022.
  • 18 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2023.

Based on Dimension Capital Management's 13F filing for Q1 2023, filed 12 May 2023.